Factor VIII Use in the Treatment of Breakthrough Bleeds in People with Moderate or Mild Hemophilia A without Factor VIII Inhibitors Receiving Emicizumab Prophylaxis: The Phase III HAVEN 6 Experience
Jiménez-Yuste, Víctor ; Lim, Elise ; Mistry, Ketna ; Ventriglia, Giuliana ; Shapiro, Amy D.
Blood, 2023-11, Vol.142 (Supplement 1), p.3999-3999 [Periódico revisado por pares]Texto completo disponível